Health News
Europe can achieve herd immunity against the coronavirus within three to four months, the head of German pharmaceutical company BioNTech, which developed the first widely approved COVID-19 vaccine
Read More
Health News
German firm BioNTech warned Tuesday there is no data backing the “safety and efficacy” of delaying the second shot of its COVID-19 vaccine beyond three weeks, as some
Read More
Medications
Thursday, December 10, 2020 – Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated
Read More